Costco to sell Ozempic and Wegovy at a large discount for people without insurance
Novo Nordisk, the company that makes Ozempic and Wegovy, announced Friday it will be selling the prescription injectable pens at Costco pharmacies.
Analyst Explains Why Eli Lilly (LLY) GLP-1 Advantage is Decreasing
Post Content
Obesity, diabetes, and inflammation: Pathophysiology and clinical implications
Obesity and its related disorders are now recognized as chronic inflammatory conditions. Donath and Drucker review the mechanisms underlying inflammation in these settings and discuss how understanding the mechanisms whereby Glucagon-like peptide-1 (GLP-1) receptor agonists function may unlock further therapeutic potential in chronic inflammatory diseases.
New Products: Shakelee, Todo Latch on to GLP-1 Trend; Seasonal LTOs from Wynk, Juni
This week’s new product roundup features GLP-1-friendly innovation from Todo and Shakelee, the debut of a “kratom brewski” and seasonal limited releases from Juni, Q Mixers and Wynk.
Analyst Explains Why Eli Lilly (LLY) GLP-1 Advantage is Decreasing
We recently published 10 Stocks to Watch Ahead of Q3 Earnings Season. Eli Lilly and Company (NYSE:LLY) is one of the stocks that Wall Street analysts are discussing these days. Don Kaufman of TheoTrade said in a recent program on Schwab Network that Eli Lilly And Co (NYSE:LLY) edge in the GLP-1 drugs is thinning […]
The Ego Problem
In the gleaming corridors of Harvard’s laboratories, where researchers pursue breakthrough discoveries that could transform medicine and technology, a quieter challenge is taking shape. Scientists are beginning to confront an uncomfortable truth: their own confidence, while essential for pushing boundaries, can sometimes become their greatest obstacle. The very assurance that drives researchers to tackle impossible […]
Paralyzed man walks again after experimental drug trial triggers remarkable recovery
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to […]
Bariatric surgery results in more weight loss compared to GLP-1s, says new study after Carnie Wilson’s ‘scary’ ordeal
The Journal of the American Medical Association (JAMA) recently published research showing that bariatric surgery results in more significant weight loss and lower long-term costs compared to GLP-1 medications. Experts discuss the effectiveness of various weight-loss surgeries.
GLP-1-friendly snacks: protein-packed NPD
Weightloss drugs are changing the way people snack and brands are answering with protein-packed launches designed to keep cravings at bay while delivering serious flavor.
The GLP-1 Arms Race, Explained
The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition. Now more heavyweights, like Pfizer and Astrazeneca, are entering the ring. Who will come out on top?